Background: Diabetes mellitus has been linked with a variety of perioperative adverse events across surgical disciplines. There is a paucity of studies systematically examining risk factors, including diabetes, and complications of aesthetic surgical procedures. Objectives: The purpose of this study was to compare incidence and type of complications between diabetic and non-diabetic patients undergoing various aesthetic surgical procedures, to identify specific procedures where diabetes significantly increases risk of complications, and to study diabetes as an independent risk factor for major complications following aesthetic surgery. Methods: A prospective cohort of 129,007 patients who enrolled into the CosmetAssure insurance program and underwent cosmetic surgical procedures between May 2008 and May 2013 were reviewed. Diabetes was evaluated as risk factor for major complications, requiring hospital admission, emergency room visit, or a reoperation within 30 days after surgery. Multivariate regression analysis was performed controlling for the effects of age, smoking, obesity, gender, type of procedures, and surgical facility. Results: Overall, 2506 patients (1.9%) had a major complication. Diabetics had significantly more complications compared to non-diabetics (3.1% vs 1.9%, P < 0.01). In univariate analysis, infectious (1.1% vs 0.5%, P < 0.01) and pulmonary (0.3% vs 0.1%, P < 0.01) complications were significantly higher among diabetics. Notably, diabetics had higher risks of complication in body cases (4.3% vs 2.6%, P < 0.01) and specifically abdominoplasty (6.1% vs 3.0%, P < 0.01). In multivariate analysis, diabetes was found to be an independent risk factor of any complication (relative risk 1.31, P = 0.03) and infection (relative risk 1.70, P < 0.01). Conclusions: Diabetes is an independent risk factor of major complications, particularly infection, after aesthetic surgical procedures.
Diabetes mellitus is a common chronic disease affecting 9%, or 29 million, of the US population 1 and is considered a risk factor for a variety of perioperative adverse events. Hyperglycemia has been shown to increase risk of surgical site infection, increased length of stay, in-hospital complications, and mortality in cardiac and general surgery patients. [2] [3] [4] [5] There is a paucity of studies systematically examining risk factors and complications of aesthetic surgical procedures. Obesity is associated with increased costs and complications in multiple studies examining common operations in plastic surgery. [6] [7] [8] [9] [10] There is an established association between obesity and type II diabetes. The likelihood and severity of type II diabetes are closely linked with body mass index (BMI). There is a seven times greater risk of diabetes in obese people compared to those of healthy weight, with a 3-fold increase in risk for overweight people. 11 Thus diabetes, like obesity, can be a modifiable risk factor.
Studies examining diabetes as a risk factor in plastic surgery have yielded varied results. Diabetes does not appear to increase early complications in hand surgery, 12 but higher incidences of wound complications in abdominoplasty 13 and skin flap necrosis in mastectomies 14 in diabetics have been described. Studies on readmission rates in diabetics also show conflicting results. [15] [16] [17] A recent analysis of the National Surgical Quality Improvement Program (NSQIP) data found that diabetics are not at higher risk for reoperation in outpatient plastic surgery. 18 Currently, plastic surgeons approach diabetic patients with caution but with no definitive evidence to guide their decision to operate or to inform their patients of the risks.
The objectives of this study are to define the prevalence of diabetes in patients undergoing aesthetic surgery procedures in a large, prospective, multicenter database (CosmetAssure, Birmingham, AL); to compare incidence and type of complications between diabetic and non-diabetic patients undergoing various aesthetic surgical procedures; to identify specific procedures where diabetes significantly increases risk of complications; and to study diabetes as an independent risk factor for major complications following aesthetic surgery.
METHODS

Study Population
This prospective cohort study was approved by the Vanderbilt University Institutional Review Board (IRB # 140082). The study population was comprised of a cohort of patients who enrolled into the CosmetAssure insurance program and underwent cosmetic surgical procedure(s) between May 2008 and May 2013. The CosmetAssure database was accessed in February 2014 following IRB approval.
Database
CosmetAssure is an insurance program that covers the cost of unexpected major complications from 24 covered cosmetic surgical procedures which may not be reimbursed by the patient's primary insurer. CosmetAssure was introduced in 2003 and has been collecting data on patient risk factors since 2008. This insurance program covers all 50 states in the United States. It is available to American Board of Plastic Surgery (ABPS)-certified plastic surgeons and is endorsed by the American Society of Plastic Surgeons (ASPS). The program is also available to ASPS Candidates for Membership who have passed the ABPS Written Examination. Every patient undergoing any covered procedure at participating practices is required to enroll in the program. Patients are entered in the database prior to undergoing the operation or occurrence of complication, thus making it a prospective cohort. Surgeon-reported major complications, filed as a claim, are recorded in the database. Personnel employed by CosmetAssure enter data provided by the surgeon at the time of patient enrollment, as well as any claims filed by the surgeon. CosmetAssure, being a private insurance company, has a vested interest in maintaining an accurate database for actuarial and audit purposes. Major complication is defined as that occurring within 30 days of the operation that requires hospital admission, an emergency room visit, or a reoperation. This excludes complications that can be managed in clinic, such as minor wound infections and seromas, as they are not applicable for insurance claim. The covered major complications include hematoma, infection, pulmonary dysfunction, cardiac complication, suspected or confirmed VTE (venous thromboembolism), myocardial infarction, and fluid overload. Other major complications (nerve injury, urinary retention, etc.) have been reported to CosmetAssure but may not qualify for compensation. The database lists all procedures performed on the patient, making it possible to study specific individual procedures as well as procedure combinations (ie, patients undergoing multiple procedures under the same anesthetic). The database also records demographic and comorbidity data including age, gender, BMI, smoking, diabetes, and type of surgical facility (accredited surgical centers [ASC], hospitals, and office-based surgical suites [OBSS] ).
Exposure
In this study cohort, exposure was defined as patient reported diagnosis of diabetes at the time of surgery (Figure 1 ).
Outcome
Primary outcome was occurrence of any major complication(s) (as defined above) within 30 days of the procedure (Figure 1 ). Secondary outcome studied was the type of complication.
Demographic Variables and Surgical Procedures
Distribution of factors including age, gender, smoking, BMI, type of procedures, and combined procedures were compared between the exposed (Diabetic) and unexposed (Non-Diabetic) populations. The dataset included 24 unique cosmetic surgical procedures, and patients underwent anywhere from 1 to 7 procedures, resulting in 727 procedure combinations. Thus, for the purpose of this study, we categorized all cosmetic procedures into 3 groups based on body region. These groups were face (blepharoplasty, browlift, cheek implant, chin augmentation, facelift, facial resurfacing, hair replacement, otoplasty, rhinoplasty), breast (augmentation, reduction, revisional breast implant procedures, mastopexy, male breast surgery), and body (abdominoplasty, brachioplasty, buttock lift, calf implant, labioplasty, liposuction, lower bodylift, thighlift, upper bodylift). Patients who underwent more than one cosmetic procedure under the same anesthetic were considered to have combined procedures. In addition, we looked at outcomes in each of the 24 surgical procedures performed as a solitary procedure to offset the potential effect-modification from combined procedures.
Statistical Analysis
Two separate, de-identified, datasets were obtained from CosmetAssure, one with the enrollment data and other with claims information. The enrollment dataset contained entries for each unique procedure. Thus, a patient undergoing combined procedures had separate entries for each procedure. A unique identifier was created using variables; date of birth, date of surgery, and BMI. Using this unique identifier, the enrollment dataset was restructured such that a patient undergoing combined procedures was counted once, with each of the procedures listed as a separate variable. Another unique identifier was created with variables shared between the enrollment and claims datasets; date of birth, date of surgery, and gender. This identifier was then used to match the claims dataset to the restructured enrollment dataset. Of the 2506 patients in the claims dataset, 20 did not match to the enrollment data using the identifier. These cases were manually matched to enrollee's with the closest demographic characteristics. Kolmogorov-Smirnov statistic was used to check normal distribution of continuous variables; age and BMI. The only missing data were absent BMI information for 1046 (0.8%) patients. These patients were included in the analysis without replacing these missing data points. Patient characteristics, risk factors, type of procedures, and complication rates between the exposure groups were compared by two-tailed t test, Fisher exact test, or by Pearson chi-square tests. For the purpose of univariate analysis, age and BMI were recoded as ordinal variables with clinically appropriate categories. Standard logistic regression analysis was performed to identify the independent risk factors for postoperative complications. For the purpose of logistic regression analysis, age and BMI were recoded to a dichotomous scale (Age ≥ 55 Years/< 55 Years, BMI ≥ 30/ <30). Outcomes were reported as 30-day incidence rates after the surgery. Unless otherwise noted, probability of type I error of <5% (P < 0.05) was used to determine statistical significance. All analyses were performed using IBM SPSS Statistics 23.0 software (IBM Corporation, Armonk, NY). ). There were 8357 men (6.5%) and 120,650 women (93.5%) in the dataset. Active smoking was reported by 10,621 (8.2%) patients. Pre-existing diabetes was recorded in 2368 (1.8%) of patients, forming the exposure group of our cohort ( Table 1) . The remaining 126,639 patients without diabetes represented the non-exposed group.
RESULTS
Clinical and Demographic Characteristics
The diabetic patients were older with a mean age of 49.1 ± 14.4 years compared to 40.7 ± 13.9 years in the nondiabetic patients (P < 0.01). Significantly, more diabetics were over the age of 55 (40.2% vs 18.1%, P < 0.01). There were more men (9.1% vs 6.4%, P < 0.01) and smokers (11.4% vs 8.2%, P < 0.01) in the diabetic group. Sixty-five percent of the diabetic patients were overweight or obese (BMI ≥ 25) compared to 35.7% of the non-diabetic patients (P < 0.01). Diabetics were more likely to have their operations in a hospital (35.5% vs 26.6%, P < 0.01) ( Table 1) . Table 2 demonstrates the frequency distribution of various aesthetic surgical procedures, performed as solitary or combined procedures, among diabetics and non-diabetics. Across the cohort, breast procedures were the most common (57.1%), followed by body (37.6%), and face (19.4%) procedures.
Type of Surgical Procedures
More diabetic patients underwent body (51.8% vs 37.3%) or face (24.9% vs 19.3%) procedures compared to non-diabetics. However, they were less likely to undergo breast procedures (37.0% vs 57.4%). The most commonly performed procedures on diabetics were abdominoplasty (30.6%), breast augmentation (26.8%), liposuction (26.7%), blepharoplasty (15.9%), mastopexy (12.9%), and facelift (12.8%). Among non-diabetics, the most common procedures were breast augmentation (46.9%), liposuction (24%), abdominoplasty (19.5%), mastopexy (15%), blepharoplasty (9.2%), and facelift (8.7%). Interestingly, diabetics were more likely to undergo combined procedures than the nondiabetic patients (36.9% vs 32.4%, P < 0.01) ( Table 1) .
Analysis of Complications
Among all patients, 2506 (1.94%) had a major complication ( Figure 1 ). Of these 2506 patients, 110 had more than one major complication (2 complications in 110 patients, 3 in 3 patients, and 4 in 1 patient) resulting in a total of 2625 complications.
On univariate analysis, diabetics had significantly more complications compared to non-diabetics (3.13% vs 1.92%, P < 0.01) ( Table 1) . Specifically, infectious (1.1% vs 0.5%, P < 0.01) and pulmonary (0.3% vs 0.1%, P < 0.01) complications were significantly higher among diabetics. The incidence of hematoma was also noted to be higher in diabetics; though not quite statistically significant (1.3% vs 0.9%, P < 0.07). Other major complications had too few occurrences in the diabetic cohort for meaningful statistical comparison (Table 3) .
Association between Diabetes and Complications in Different Aesthetic Procedures
When stratified by the body region being operated (breast, body, face, or any combination of regions), diabetics had significantly higher complications in body procedures (4.3% vs 2.6%, P < 0.01). Similarly, in other regions, diabetics suffered more complications though the difference was not statistically significant ( Figure 2 ). Association between diabetes and complications following commonly performed procedures is shown in Table 4 . Diabetics undergoing abdominoplasty had double the incidence of major complications of non-diabetics (6.1% vs 3.0%, P < 0.01). A statistically significant increase in complications was also noted following facelift-blepharoplasty combination (6.8% vs 2.2%, P = 0.03), however, with only 5 adverse events in this diabetes subgroup this statistic should be interpreted with caution.
Association between Diabetes and Complications Across BMI Categories
As previously noted, diabetic patients were nearly twice as likely to be overweight or obese compared to the nondiabetic patients (65% vs 35.7%, P < 0.01) ( Table 1) . To account for the confounding effect that BMI may have on association between diabetes and complications, we performed a stratified analysis across 3 BMI categories: normal weight (BMI < 25), overweight (BMI 25-29.9), and obese (BMI ≥ 30). We found that the significant association between diabetes and complications was limited only to obese patients (5.2% vs 3.1%, P < 0.01) ( Figure 3A ). This Sum of percentages of different body regions exceeds 100 because majority of patients underwent more than one procedure. For the same reason, sum of percentages within a given body region may exceed the total percent for that body region.
finding was replicated when we specifically looked at infections (2.5% vs 1.1%, P < 0.01) ( Figure 3B ) and pulmonary complications (2.5% vs 1.1%, P = 0.02) ( Figure 3C ).
Diabetes as an Independent Risk Factor for Major Complications
In addition to the stratified analysis to identify potential confounders, we performed multivariate logistic regression analysis to evaluate diabetes as in independent risk factor after controlling for the effects of age, smoking, obesity, gender, type of procedures, and surgical facility. We found diabetes to be an independent risk factor of any complication (relative risk 1.31, 95% confidence interval 1.03-1.67, P = 0.03) ( Table 5 ) and infection (relative risk 1.70, 95% confidence interval 1.14-2.52, P < 0.01) ( Table 6 ). While there was an elevated risk of respiratory complications in diabetics, this did not reach statistical significance (relative risk 1.98, 95% confidence interval 0.96-4.10, P = 0.06) ( Table 7) .
DISCUSSION
The prevalence of diabetes in patients undergoing cosmetic surgery is low. In the current study, only 1.8% of patients had diabetes compared to a national prevalence of 9%. The observed difference may be attributed to an interplay of multiple factors. Diabetic patients may be less likely to seek aesthetic surgery because of health concerns or may not report it on preoperative evaluation. Also, surgeons may be less inclined to offer elective surgery to diabetic patients. Despite the low prevalence, the complications can lead to severe morbidity. The detrimental effects of uncontrolled diabetes have been demonstrated in other surgical fields. Our prospective analysis highlights outcomes of diabetic patients undergoing cosmetic surgery, and specifically reveals that diabetes is an independent risk factor for major complications, most notably infection. The overall complication rate of diabetics in our review is higher than non-diabetics. Specifically, infection rates were significantly higher in diabetics. This finding is similar to previous reviews of diabetic surgical patients. Malone et al found a 4.5% surgical site infection rate in diabetic patients undergoing non-cardiac surgery. 2 Frisch et al found higher incidences of surgical site infection (5%), systemic blood infections (3.6%), and urinary tract infections (4.5%) in diabetic patients undergoing non-cardiac surgery. 5 Diabetics are at higher risk of infection due to impaired immune function secondary to hyperglycemia. Studies have demonstrated decreased granulocyte function and microbicidal action in diabetics. [19] [20] [21] Complications from hyperglycemia can be reduced with improved glycemic control; however, optimal perioperative glucose targets are unclear. High intensive insulin regimens are associated with minimal benefits and the risk of hypoglycemia. 22 In our study, we only examined the presence or absence of diabetes. We did not stratify Figure 2 . Univariate analysis of association between diabetes and complications following procedures on different body regions. Breast (augmentation, mastopexy, reduction, gynecomastia); body (buttock lift, calf implant, labiaplasty, lower body lift, thigh lift, brachiplasty, upper body lift); face (blepharoplasty, browlift, cheek implant, chin augmentation, facelift, facial resurfacing, hair replacement, otoplasty, rhinoplasty). * Numbers in red indicate statistical significance, P-value of < 0.05. by hemoglobin A1c as this is not routinely measured in this patient population and this data is not recorded by CosmetAssure. The best perioperative strategy is to preoperatively optimize diabetic regimens in conjunction with primary care physicians. Diabetics should be monitored for postoperative hyperglycemia and should return to their home regimen as soon as possible. Our review also showed a slightly higher incidence of respiratory complications in diabetic patients, including both pneumonia and respiratory failure. The diabetic population is at higher risk of nosocomial pneumonia. Frisch et al found higher rates of pneumonia (12.1%) in postoperative diabetic patients. 5 In our analysis, diabetes was associated with respiratory complications but did not reach statistical significance to qualify as an independent risk factor (relative risk 1.98, 95% confidence interval 0.96-4.10, P = 0.06). Respiratory complications are likely multifactorial and may be the result of interplay between comorbidities such as diabetes and obesity. There is an established relationship between diabetes and obstructive sleep apnea (OSA), 23 and it is common for OSA to be undiagnosed. Patients with OSA are at risk for acute respiratory failure and postoperative oxygen desaturation. 24 The use of general anesthesia may also increase risk of respiratory complications. Postoperative respiratory complications have been observed in patients with obstructive sleep apnea undergoing general anesthesia. 25 However, choice of anesthetic was not associated with early complications after hand surgery in the NSQIP database. 12 Unfortunately, information on anesthetic technique was not available for our analysis. Respiratory complications in the cosmetic surgery population are rare but can be devastating. Proper preoperative evaluation of diabetes and associated comorbidities is imperative to help reduce this risk.
In our review, patients with diabetes had an average BMI three points higher than non-diabetics. We found that patients with an elevated BMI and diabetes were at an even higher risk of complication. These findings are even more pronounced in those with a BMI over 30. Patients and providers should be aware of the higher risk for this patient population. There is a known relationship between obesity and diabetes in that obesity is a risk factor for developing diabetes. With our large database, we were able to compare the effect of diabetes on complication across different strata of BMI, and ultimately establish diabetes as an independent risk factor irrespective of BMI.
Our analysis revealed that diabetics are more prone to complications in body procedures compared to other cosmetic procedures. Complications, including infection, were significantly higher in the abdominoplasty group. This confirms a previous study examining outcomes of consecutive abdominoplasties. 26 Diabetes contributes to small vessel disease, which affects wound healing. This likely has a larger effect on body cases compared to face or breast cases, due to the location and size of incisions. Not all breast, body, and face procedures are created equal within each subgroup. Our study included examining more than 700 procedure combinations in our dataset, but it is difficult to study the effect on every permutation. For simplicity, we have grouped the procedures by body region to give an overall picture. We found that procedures on breast or face have lower complication rates than procedures on the rest of the body. We have also reported complications in specific, frequently performed, procedures or combinations (Table 4) . When combining cases, there is a slight trend for increased complications in diabetics, but this finding did not reach significance. Increased risk in combination abdominal and breast cases was recently described in patients with multiple risk factors. 27 Optimizing diabetes control and other comorbidities for combination cases is essential in reducing risk.
Diabetes may also be associated with minor wound complications such as delayed healing, superficial infections, and dehiscence. A recent meta-analysis revealed that diabetes is associated with an increased risk of surgical site infections. 28 Another study demonstrated that diabetes was an independent risk factor for surgical site occurrences such as infection and wound dehiscence in ventral hernia repairs. 29 Unfortunately, such complications are likely managed in a clinic setting and were not recorded in our database.
Preoperative evaluation is of utmost importance in any elective surgery. Optimizing medical conditions and identifying potential risk factors is as essential as operative planning in order to reduce risk. This is especially important in the cosmetic surgery patients who tend to be younger and may not regularly see their primary care physician, unlike their older counterparts. A perioperative plan for diabetes control is our best tool to reduce risk in diabetic patients.
To the best of our knowledge, this study represents the largest investigation looking at the effect of diabetes on complications of aesthetic surgery procedures. The CosmetAssure insurance database is a powerful tool for assessment of clinical outcomes of cosmetic surgery. It provides prospectively collected data, which is necessary for determining the true incidence of complications and risk factors. It is a multi-center database encompassing hospitals, ASCs, and OBSS, making the results generalizable to a wide variety of practice models. It is robust in establishing a baseline complication rate following various procedure combinations. A previous study has shown cross-validation of CosmetAssure data with the Tracking Operations and Outcomes for Plastic Surgeons (TOPS). 30 Since CosmetAssure offers a significant incentive to a surgeon for reporting a complication, in the form of payment of the claim, this database offers a major advantage over other registries by potentially minimizing the underreporting of complications. In addition, the dataset is validated by a similar patient profile as that reported by the American Society for Aesthetic Plastic Surgery (ASAPS). 31 The relative frequency of procedures is different as the ASAPS estimate reports are based on data not only from plastic surgeons, but also from otolaryngologists and dermatologists. The database goes a step further by establishing the minimum surgeon qualification (plastic surgeons who are certified or are candidates for certification by the ABPS), thus avoiding variability in complications attributable to the credentials of the healthcare provider.
While the CosmetAssure database has many advantages, some of its limitations merit discussion. The BMI information was missing for 1046 (0.8%) patients in the database. We used BMI, along with date of surgery and date of birth, to create a unique identifier for restructuring the enrollment dataset. Multiple quality control measures were performed to confirm accuracy of restructuring. We manually looked at information on each patient who was missing BMI information from the unique identifier. There was no indication that more than one patient may have the same identifier due to this missing information. There was consistency in the type of facility and no duplication of the type of procedure. After linking the enrollment and claims datasets using another unique identifier, created with variables shared between the two datasets (date of birth, date of surgery, and gender), we manually checked the type of procedures between the two datasets for all 2506 complications. This again demonstrated accuracy of the restructuring and linking procedures. Excluding the 1046 patients with missing BMI information from analysis would have resulted in loss of valuable data on other variables. In terms of risk factor analysis, the regression model automatically excluded cases with missing data. It is possible that despite these considerations there may be errors in information on a few patients.
The database fails to include minor, but clinically significant, complications (minor infection, wound breakdown, seroma etc.) since these are managed in the clinic and do not require hospitalization, emergency room visit, or reoperation. These complications are significantly more common than major complications, and important in cosmetic outcomes and patient perceived results. The database does not register complications occurring after 30 days of the operation. This results in unknown final outcomes after the management of these complications. The database does not differentiate between different techniques of a particular procedure which may predispose patients to certain complications. No information is available on measures such as ASA class, VTE prophylaxis, preoperative antibiotics, intraoperative temperature and blood pressure management, and duration of surgery and thus their impact cannot be analyzed. One limitation to our study is that our database does not provide details of the diagnosis of diabetes. We do not have information about whether patients had type I or type II diabetes or even pre-diabetes. However, stratifying patients by type of diabetes would not likely reveal any differences due to the fact that the pathogenesis of increased surgical complications is related to hyperglycemia, which is present in both types. Control of hyperglycemia is an important facet of perioperative diabetes care, which can be more cumbersome in type I diabetics who require basal insulin. Our database also lacks information on perioperative glycemic control as well as a recent glycosylated hemoglobin (HbA1c) level, a marker of long-term glucose control. This is a key factor in surgical risk in diabetics, but it is difficult to obtain outside of a research protocol. HbA1c is not routinely measured in aesthetic surgery and was likely followed by the patient's primary provider. Information on the use of oral hypoglycemic agents or insulin may have given insight into the severity of diabetes, but this was not tracked in our database.
Additionally, it is possible that the prevalence of diabetes in our database is under-reported. It has been estimated that approximately 25% of people with diabetes are undiagnosed. 32 This finding would infer that our complication rates are actually underestimated. This especially may be important in our patient population undergoing bodycontouring procedures. A review by Constantine et al found patients with massive weight loss had a higher risk of wound complications, 33 and patients with massive weight loss commonly have a diagnosis of diabetes.
The database also lacks comprehensive information about patients' other comorbidities. Diabetes is associated with multiple comorbid conditions such as coronary heart disease, hypertension, dyslipidemia, and fatty liver disease, which may contribute to surgical risk. However, these comorbid conditions would likely contribute to complications not observed in our study such as myocardial infarction and mortality. Additionally, assessment of available health conditions (diabetes, obesity, and smoking) suggest that the patient population seeking cosmetic surgery is significantly healthier compared to the general population of the United States, with low burden of comorbid conditions. Finally, CosmetAssure is used by only a fraction of eligible plastic surgeons in the United States.
Despite this study's limitations, our review provides an insight into the complication rates diabetics' face in cosmetic surgery. As expected, overall complication rates are higher in diabetics, especially with regards to infections rates and abdominoplasties. Interestingly, the effect of diabetes on complications was most prominent in obese patients. In an era of increased awareness of outcomes and patient satisfaction, it is important for both providers and patients to be aware of these risks, and appropriate steps should be taken on a case-by-case basis to help reduce those risks.
CONCLUSION
Prevalence of diabetes among aesthetic surgery patients is low. Diabetic patients undergo more body procedures and combined procedures compared to non-diabetic patients. Diabetes is associated with increased major complications in body procedures. Association of diabetes and complications is most prominent in obese patients. Diabetes is an independent risk factor of major complications, particularly infection, after aesthetic surgical procedures.
